Big Biogen boost on Alzheimer's news could win back biotech investors
By Lewis KrauskopfNEW YORK, June 7 (Reuters) - The approval by U.S. regulators on Monday of a Biogen Inc drug to treat Alzheimer's disease could...
By Lewis KrauskopfNEW YORK, June 7 (Reuters) - The approval by U.S. regulators on Monday of a Biogen Inc drug to treat Alzheimer's disease could...